Tag: Biontech

Biotechnology major Moderna on Friday sued rival Pfizer and BioNTech over alleged infringement of its messenger RNA (mRNA) vaccine technology patents.

The trials would evaluate the safety, tolerability and immunogenicity of the vaccine candidate, according to a joint statement by the companies on Tuesday. The study would involve up to 1,420 participants.

COVID19 Third Wave Is Here’ | Top COVID, OMICRON Headlines

The latest research from South Africa, where Omicron was first reported, suggested that two doses of the Pfizer/BioNTech vaccine offered 70 per cent effectiveness in reducing the risk of hospitalisation. Israeli researchers have also found that the booster doses of the vaccine works against Omicron.

"The vaccine is one-third the adult dose and the vaccine would be given in two doses, three weeks apart. "

If authorised, Pfizer-BioNTech vaccine would be the first Covid-19 vaccine for younger children.

New York: Global pharmaceutical major Pfizer believes that a Covid-19 vaccine could be ready by the end of October, the company’s CEO Albert Bourla said. Pfizer is conducting clinical trials in the US and Europe for the BNT162 vaccine programme to prevent Covid-19 in collaboration with German mRNA company BioNTech. Bourla made the comments while […]

New York: Taking a big jump towards delivering an effective vaccine to fight the pandemic, US-based pharmaceutical major Pfizer and German biotech firm BioNTech on Monday said that their vaccine candidate was found to be more than 90 per cent effective in preventing Covid-19 in first interim analysis of data from late stage Phase-3 trial. […]

New York: Pfizer and its German partner BioNTech released a second batch of interim results on Wednesday, saying their coronavirus vaccine candidate is 95 per cent effective and also protects the most vulnerable people in older age groups from the risk of falling prey to the virus. “Primary efficacy analysis demonstrates BNT162b2 to be 95 […]

Washington: The first Americans to receive a COVID-19 vaccine could get it as soon as December 11 or 12, the White House vaccine czar said on Sunday. On Friday, American pharmaceutical giant Pfizer and its German partner BioNTech submitted an application to the US Food and Drug Administration for emergency use authorisation for its COVID-19 […]

London: As the world grapples with the pandemic amid the origin of newer and potentially lethal strains, BioNTech CEO Ugur Sahin has said that the deadly virus is going to stay with us for the next decade at least. In a virtual press conference this week, Sahin spoke about the potential virus deadline when asked […]